Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
DSS ( (DSS) ) has issued an announcement.
On July 21, 2025, DSS, Inc. entered into a Debt Conversion Agreement with Impact Biomedical Inc. to settle a $12 million revolving promissory note originally issued in March 2023. This agreement involved DSS receiving 31,939,778 shares of Impact’s common stock, fully satisfying all outstanding debts and obligations owed by Impact to DSS, potentially impacting DSS’s financial position and stakeholder interests.
More about DSS
Average Trading Volume: 85,577
Technical Sentiment Signal: Sell
Current Market Cap: $10.55M
For a thorough assessment of DSS stock, go to TipRanks’ Stock Analysis page.